UnitedHealthvsVoyager Therapeutics

UNH and VYGR stock compared: price, dividend, valuation and results, from SEC filings.

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

VYGR

Voyager Therapeutics, Inc.

$1.61

Value $96M

-3.59%
VYGR's page

UnitedHealth (UNH) has a market value of $300B and Voyager Therapeutics (VYGR) $96M. Over the last year, with dividends, UNH moved +8.2% and VYGR -62.4%. Dividend yield: UNH 2.74%, VYGR none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    UNH$300B

    VYGR$96M

    UNH is 3,126 times VYGR

  • Revenue, 12 months

    UNH$450B

    VYGR$25M

    UNH is 17,909 times VYGR

  • Net income, 12 months

    UNH$15.9B

    VYGR-$105M

  • Operating margin

    UNH5.3%

    VYGR-450.1%

    455.4 points apart

  • ROIC

    UNH11.3%

    VYGR-50.8%

    62.1 points apart

  • P/E

    UNH18.9

    VYGR–

  • Dividend yield

    UNH2.7%

    VYGR0.0%

    2.7 points apart

  • 5-year return

    UNH-19.5%

    VYGR-49.1%

    29.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

UNH-19.5%

VYGR-49.0%

20040020222023202420252026
Returns by period
PeriodUNHWith dividendsVYGRWith dividends
1 year since November 18, 2025+8.2%Price +5.4%-62.4%Price -62.4%
3 years since November 17, 2023-34.4%-13.1% a yearPrice -38.4%-76.4%-38.2% a yearPrice -76.4%
5 years since November 18, 2021-19.5%-4.2% a yearPrice -26.5%-49.1%-12.6% a yearPrice -49.1%
10 years since November 21, 2016+159.4%+10.0% a yearPrice +119.7%-88.5%-19.4% a yearPrice -88.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

UNHUnitedHealthVYGRVoyager Therapeutics

Valuation

UNHVYGR
Valuation
Price$330.48$1.61
Market value$300B$96M
Enterprise value (EV)$346B–
P/E18.9–
P/E, 5-year median25.0–
P/B2.90.7
EV/EBIT14.5–
Free cash flow yield7.6%–

Results and growth

UNHVYGR
Results and growth
Revenue, 12 months$450B$25M
Net income, 12 months$15.9B-$105M
Free cash flow, 12 months$22.8B-$110M
Earnings per share, 12 months$17.52-$1.74
Revenue growth, year on year11.8%-49.5%
Revenue growth a year, past+11.7%over 5 years-25.1%over 5 years
EPS growth a year, past-3.8%over 5 years–

Margins and returns on capital

UNHVYGR
Margins and returns on capital
Gross margin88.3%–
Operating margin5.3%-450.1%
Net margin3.5%-416.3%
ROIC11.3%-50.8%
ROE15.5%-59.5%

Balance sheet

UNHVYGR
Balance sheet
Cash$28.5B$132M
Total debt$74.3B$31M
Net debt / EBITDA1.6–
Interest cover6.2×–

Dividends and buybacks

UNHVYGR
Dividends and buybacks
Dividend yield2.7%–
Dividend per share, 12 months$9.06–
Dividend growth a year, past+12.6%over 5 years–
Buyback yield1.8%–
Shareholder yield4.6%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: UNH or VYGR

Didn't find what you were looking for?

Ask us
Which is bigger, UnitedHealth or Voyager Therapeutics?

By market value, UnitedHealth ($300B) is about 3,126.1 times Voyager Therapeutics ($96M), at today's prices.

How did UNH and VYGR stock do over the last 10 years?

Since November 21, 2016, UNH's price moved +119.7% and VYGR's -88.5%. With dividends: UNH +159.4% (+10.0% a year), VYGR -88.5% (-19.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, UNH or VYGR?

The dividend yield at today's price is 2.74% for UnitedHealth and none for Voyager Therapeutics. Over the last twelve months they paid $9.06 and – per share.

Which has the higher profit margins, UnitedHealth or Voyager Therapeutics?

Over the last twelve months, the net margin was 3.5% for UnitedHealth and -416.3% for Voyager Therapeutics, and the operating margin 5.3% and -450.1%. Revenue was $450B and $25M.

Which is the better investment, UnitedHealth or Voyager Therapeutics?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.